Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Bayer expects 2025 to be the most difficult year of its turnaround
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC), if approved
Antibe Therapeutics is a clinical-stage biotechnological company developing novel drugs primarily focusing on reducing pain and inflammation
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
Lupin updates on shipment of Mirabegron ER Tablets
Subscribe To Our Newsletter & Stay Updated
